MoneyWorks4Me

Hester Biosciences - Quaterly Results

31 Jul 2026 Evaluate
The revenue for the June 2026 quarter is pegged at Rs. 726.60 millions, about 14.44% up against Rs. 634.90 millions recorded during the year-ago period.Profit after tax for the quarter ended June 2026 reported a huge growth of 87.69% to Rs. 147.11  millions from Rs. 78.38 millions.The company reported a good operating profit of 260.34 millions compared to 133.57 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 726.60 634.90 14.44 726.60 634.90 14.44 2921.36 2864.66 1.98
Other Income 16.83 9.46 77.91 16.83 9.46 77.91 76.35 47.64 60.26
PBIDT 260.34 133.57 94.91 260.34 133.57 94.91 801.07 557.08 43.80
Interest 13.64 9.05 50.72 13.64 9.05 50.72 71.69 53.67 33.58
PBDT 246.70 124.52 98.12 246.70 124.52 98.12 799.34 503.41 58.79
Depreciation 49.18 21.64 127.26 49.18 21.64 127.26 102.52 85.81 19.47
PBT 197.52 102.88 91.99 197.52 102.88 91.99 696.82 417.60 66.86
TAX 50.41 24.50 105.76 50.41 24.50 105.76 175.82 99.18 77.27
Deferred Tax 4.84 6.12 -20.92 4.84 6.12 -20.92 31.16 -13.52 -330.47
PAT 147.11 78.38 87.69 147.11 78.38 87.69 521.00 318.42 63.62
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 35.83 21.04 70.31 35.83 21.04 70.31 27.42 19.45 41.01
Peers
Company Name CMP
Sun Pharma. Inds. 1850.00
Dr. Reddys Labs. 1212.75
Cipla 1374.75
Lupin 2096.35
Zydus Lifesciences 1168.15
View more..